TSW
ROIV icon

Thompson Siegel & Walmsley’s Roivant Sciences ROIV Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-282,624
Closed -$4.28M – 424
2025
Q3 		$4.28M Sell
282,624
-244,450
-46% -$3.03M 0.07% 239
2025
Q2 		$5.94M Sell
527,074
-5,690
-1% -$61.7K 0.1% 195
2025
Q1 		$5.38M Sell
532,764
-32,573
-6% -$352K 0.09% 181
2024
Q4 		$6.69M Buy
565,337
+51,705
+10% +$611K 0.1% 167
2024
Q3 		$5.93M Buy
+513,632
New +$5.85M 0.09% 183

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.27B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return